Search for the latest oncology news by tumour type
On May 19, 2020, the Food and Drug Administration approved olaparib for adult patients with…
“Senotherapy”, a treatment that uses small molecule drugs to target “senescent” cells, or those cells…
Prostate cancer patients who do not respond well to PSMA-targeted therapy often have potentially treatable…
Access to targeted therapies for lung cancer depends on accurate identification of patients’ biomarkers through…
Merck has announced positive results from the Phase 3 KEYNOTE-355 trial investigating pembrolizumab in combination with…
Scientists show in-vivo and in-vitro how liver cancer stem cells are born, solving a central…
Results of a comprehensive analysis of exercise and its protective role for high-risk breast cancer…
In the most comprehensive review to date of how breast cancer develops, scientists have created…
Two novel biomarkers have been found to correlate with improved outcomes with immunotherapy in metastatic…
The Institute of Cancer Research, London, UK, has strongly welcomed the approval by the US…